Your Cart is Empty
Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.
GLP-1 is crucial for blood sugar control, boosting insulin release and supporting glucose balance. Lower GLP-1 levels can disrupt these processes, causing insulin resistance and elevated blood sugar. Taking a statin alongside a medication like Ozempic may diminish some of its intended effects, especially those related to managing blood sugar.
The study consisted of 30 participants, taking the drug atorvastatin. They were monitored for four months with various controls. While cholesterol levels dropped as anticipated, blood sugar slightly increased, insulin resistance worsened, and GLP-1 levels decreased by nearly 50%.
The study revealed that statins modify the gut microbiome, particularly reducing Clostridium bacteria, which produce UDCA, a bile acid that supports GLP-1 production. With reduced microbes, UDCA levels dropped, leading to lower GLP-1. Essentially, statins disrupted a gut microbial pathway critical for blood sugar regulation.
Many doctors prescribe statins without discussing their impact on insulin resistance or overall metabolic health. For patients managing cholesterol and blood sugar, this overlooked connection is vital.
Lifestyle interventions are indeed critical as a first-line approach to support and maintain metabolic health, especially for individuals on statins. Prioritizing lifestyle changes can enhance the effectiveness of statins, potentially reduce reliance on medication, and improve overall health.
To view the original scientific study click below:
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Recent research reveals that constipation is linked to a greater risk of heart attacks and strokes, with the danger escalating significantly in individuals who also suffer from high blood pressure. These findings underscore the importance of viewing constipation not merely as a digestive problem, but as a potential cardiovascular risk factor requiring serious attention.
Microplastics have become inescapable. We're ingesting them through food and water, and even inhaling them daily. These tiny fossil-fuel-based particles, smaller than 5 mm, have now been detected deep inside human bones, cartilage, and spinal discs. A recent study reveals that microplastics can penetrate bone tissue, including the marrow, where they may disrupt metabolic processes and harm skeletal health.
Ultra-processed foods now make up nearly 60% of calories in the average U.S. adult's diet. These highly manufactured items are increasingly dominating American eating habits. A major U.S. cohort study involving over 100,000 participants, found that those with the highest intake of ultra-processed foods had a 41% greater risk of lung cancer compared to those with the lowest intake.